Searching...
Can't find what you're looking for. Try different keywords.
Stay Informed, Stay Ahead
Olopatadine Hydrochloride
5mg
Usual adult dosage is 5 mg as olopatadine hydrochloride twice daily, in the morning and before going to bed. The dosage should be adjusted according to the age and symptoms of patients
Patadin is indicated for the treatment of Skin Allergy
Antihistaminic agent (H1 receptor inhibitor)
The half-life of Olopatadine in plasma was approximately eight to 12 hours, and elimination was predominantly through renal excretion. Approximately 60-70% of the dose was recovered in the urine as active substance. Two metabolites, the mono-desmethyl and the N-oxide, were detected at low concentrations in the urine.
Pregnancy There are, however, no adequate and well- controlled studies in pregnant women. Because animal studies are not always predictive of human responses, this drug should be used in pregnant women only if the potential benefit to the mother justifies the potential risk to the embryo or fetus. Lactation Olopatadine has been identified in the milk of nursing rats following oral administration.
No overall differences in safety and effectiveness have been observed between elderly and younger patients.
Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.
